Gene: ZFP64
Official Full Name: ZFP64 zinc finger proteinprovided by HGNC
Gene Summary: Predicted to enable DNA binding activity and metal ion binding activity. Involved in mesenchymal cell differentiation. Located in cytoplasm and megasporocyte nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12395 | ZFP64 Knockout cell line (HeLa) | Human | ZFP64 | 1:3~1:6 | Negative | Online Inquiry |
KO12396 | ZFP64 Knockout cell line (HCT 116) | Human | ZFP64 | 1:2~1:4 | Negative | Online Inquiry |
KO12397 | ZFP64 Knockout cell line (HEK293) | Human | ZFP64 | 1:3~1:6 | Negative | Online Inquiry |
KO12398 | ZFP64 Knockout cell line (A549) | Human | ZFP64 | 1:3~1:4 | Negative | Online Inquiry |
ZFP64 Gene Knockout Cell Lines are advanced biological tools specifically engineered to enhance research in gene function and regulation. These cell lines are generated using CRISPR-Cas9 technology to selectively inactivate the ZFP64 gene, leading to precise genetic modifications that facilitate the study of various biological processes, including differentiation, proliferation, and apoptosis. By removing the influence of the ZFP64 protein, researchers can observe subsequent cellular behavior and gain insights into the roles this gene plays in health and disease.
The primary mechanism of action is the introduction of targeted double-strand breaks in the genomic DNA at the ZFP64 locus, followed by error-prone repair mechanisms that result in gene knockout. This leads to a loss of function that is critical for validating gene-targeted hypotheses, particularly in studies related to developmental biology, cancer research, and regenerative medicine.
Scientifically, ZFP64 plays a crucial role in transcriptional regulation and cellular stress responses, making these knockout cell lines invaluable for both fundamental research and clinical applications. They allow for the exploration of ZFP64-related pathways, enabling researchers to develop novel therapeutic strategies, investigate disease mechanisms, and identify potential drug targets.
Compared to other gene knockout models, our ZFP64 Gene Knockout Cell Lines are distinguished by their enhanced specificity and reliability. The use of CRISPR-Cas9 technology ensures minimal off-target effects, thereby providing researchers with confidence in their experimental outcomes. Furthermore, our product line is characterized by rigorous validation and extensive characterization, guaranteeing high quality and reproducibility.
For researchers and clinicians seeking to unravel the complexities of gene function and therapeutic intervention, ZFP64 Gene Knockout Cell Lines offer a powerful platform. Their precise genetic modification capabilities make them indispensable in translational research and drug development. Our company prides itself on delivering cutting-edge biological products backed by a team of experts in genetic engineering and molecular biology, ensuring that we meet the dynamic needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.